Frailty is a predictor for worse outcomes in patients hospitalized with Clostridioides difficile infection

被引:2
|
作者
Chaar, Abdelkader [1 ]
Yoo, Jin Woo [1 ]
Nawaz, Ahmad [1 ]
Rizwan, Rabia [1 ]
Agha, Osama Qasim [1 ]
Feuerstadt, Paul
机构
[1] Yale Sch Med, New Haven, CT USA
来源
ANNALS OF GASTROENTEROLOGY | 2024年 / 37卷 / 04期
关键词
Clostridioides difficile; colitis; frailty; Hospital Frailty Risk Score;
D O I
10.20524/aog.2024.0898
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Frailty has major health implications for affected patients and is widely used in the perioperative risk assessment. The Hospital Frailty Risk Score (HFRS) is a validated score that utilizes administrative billing data to identify patients at higher risk because of frailty. We investigated the utility of the HFRS in patients with Clostridioides difficile infection (CDI) to determine whether they were at risk for worse outcomes and higher healthcare resource utilization. Methods Using the 2017 National Inpatient Sample, we identified all adults with a primary diagnosis of CDI. We classified patients into 2 groups: those who had an HFRS <5 (NonFrailCDI) and those with a score >= 5 (FrailCDI). We assessed differences in hospital outcomes and healthcare resource utilization based on frailty status. Results We identified 93,810 hospitalizations, of which 54,300 (57.88%) were FrailCDI. FrailCDI patients were at higher risk for fulminant CDI (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.6-2.3), requiring colectomy (OR 4.1, 95%CI 1.5-11.2), and inpatient mortality (OR 4.5, 95%CI 2.8-7.1). Furthermore, FrailCDI patients had higher odds of requiring Intensive Care Unit admission (OR 13.7, 95%CI 6.3-29.9) or transfer to another facility on discharge (OR 2.2, 95%CI 2.0-2.4), and had longer hospital stays and higher total charges when compared with NonFrailCDI. Conclusions Frailty as defined by the HFRS is an independent factor for worse outcomes and higher healthcare utilization in adults admitted for CDI. Risk stratifying patients by frailty may improve outcomes.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 50 条
  • [21] Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
    Patel, Ankoor H.
    Pathak, Gaurav N.
    Chen, Alexander
    Greenberg, Patricia
    Mazzaferro, Natale
    Patel, Anish
    Mallangada, Naveen
    Minacapelli, Carlos D.
    Catalano, Kaitlyn
    Suthar, Hansel
    Rustgi, Vinod K.
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [22] Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study
    Le, Puo-Hsien
    Chen, Chyi-Liang
    Kuo, Chia-Jung
    Yeh, Pai-Jui
    Chen, Chien-Chang
    Chen, Yi-Ching
    Chiu, Cheng-Tang
    Cheng, Hao-Tsai
    Tsou, Yung-Kuan
    Pan, Yu-Bin
    Chiu, Cheng-Hsun
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2025,
  • [23] Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection
    Alonso, Carolyn D.
    Kelly, Ciaran P.
    Garey, Kevin W.
    Gonzales-Luna, Anne J.
    Williams, David
    Daugherty, Kaitlyn
    Cuddemi, Christine
    Villafuerte-Galvez, Javier
    White, Nicole C.
    Chen, Xinhua
    Xu, Hua
    Sprague, Rebecca
    Barrett, Caitlin
    Miller, Mark
    Foussadier, Agnes
    Lantz, Aude
    Banz, Alice
    Pollock, Nira R.
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (12) : 2142 - 2149
  • [24] Clinical outcomes of clostridioides difficile infection in the very elderly
    Kassem, Sameer
    Hijazi, Nizar
    Stein, Nili
    Zaina, Adnan
    Ganaim, Mohammad
    INTERNAL AND EMERGENCY MEDICINE, 2024, 19 (04) : 1041 - 1049
  • [25] Does early corticosteroid therapy affect prognosis in IBD patients hospitalized with Clostridioides difficile infection?
    Bar-Yoseph, Haggai
    Daoud, Haneen
    Ben Hur, Dana
    Chowers, Yehuda
    Waterman, Matti
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2020, 35 (03) : 513 - 519
  • [26] Clostridioides difficile Infection
    Guh, Alice Y.
    Kutty, Preeta K.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (07) : ITC49 - ITC63
  • [27] Diagnosis and treatment of Clostridioides difficile infection
    Mateu, Lourdes
    Fernandez-Riva, Gema
    Sopena, Nieves
    MEDICINA CLINICA, 2020, 155 (01): : 30 - 35
  • [28] Impact of Nucleic Acid Amplification Test on Clinical Outcomes in Patients with Clostridioides difficile Infection
    Yamada, Yota
    Miyazaki, Motoyasu
    Kushima, Hisako
    Komiya, Yukie
    Nakashima, Akio
    Ishii, Hiroshi
    Imakyure, Osamu
    ANTIBIOTICS-BASEL, 2023, 12 (03):
  • [29] Risk for Clostridioides difficile Infection Among Hospitalized Patients Associated With Multiple Healthcare Exposures Prior to Admission
    Miller, Aaron C.
    Sewell, Daniel K.
    Segre, Alberto M.
    Pemmaraju, Sriram, V
    Polgreen, Philip M.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (04) : 684 - 694
  • [30] Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer
    Francisco, Denise Marie A.
    Zhang, Liangliang
    Jiang, Ying
    Olvera, Adilene
    Adachi, Javier
    Guevara, Eduardo Yepez
    Aitken, Samuel L.
    Garey, Kevin W.
    Peterson, Christine B.
    Do, Kim-Anh
    Dillon, Ryan
    Obi, Engels N.
    Jenq, Robert
    Okhuysen, Pablo C.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (01) : 209 - 225